Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load ≥10000copies/ml: A safe and effective strategy for allogeneic stem cell transplant patients

L. A. Verkruyse, G. A. Storch, S. M. Devine, J. F. DiPersio, R. Vij

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load ≥10000copies/ml: A safe and effective strategy for allogeneic stem cell transplant patients'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology